Pulmonary embolism, coagulation
| Zeile 20: | Zeile 20: | ||
*[https://townhall.com/tipsheet/leahbarkoukis/2020/05/05/doctors-are-noticing-a-dangerous-phenomenon-even-after-wuhan-coronavirus-symptoms-are-gone-n2568192 thrombotic late reactions] | *[https://townhall.com/tipsheet/leahbarkoukis/2020/05/05/doctors-are-noticing-a-dangerous-phenomenon-even-after-wuhan-coronavirus-symptoms-are-gone-n2568192 thrombotic late reactions] | ||
| − | + | ||
| Zeile 26: | Zeile 26: | ||
{{tp|p=32250159|t=2020. Hemorrhagic Problem Among the Patients With COVID-19: Clinical Summary of 41 Thai Infected Patients |pdf=|usr=}} | {{tp|p=32250159|t=2020. Hemorrhagic Problem Among the Patients With COVID-19: Clinical Summary of 41 Thai Infected Patients |pdf=|usr=}} | ||
| − | |||
| − | + | ||
| + | |||
| Zeile 43: | Zeile 43: | ||
{{tp|p=32338320|t=ä. Covid-19 treatment update: follow the scientific evidence |pdf=|usr=}} | {{tp|p=32338320|t=ä. Covid-19 treatment update: follow the scientific evidence |pdf=|usr=}} | ||
| − | + | ||
{{tp|p=32360371|t=ä. Thromboembolic events in patients with SARS-CoV-2 |pdf=|usr=}} | {{tp|p=32360371|t=ä. Thromboembolic events in patients with SARS-CoV-2 |pdf=|usr=}} | ||
| − | |||
| − | |||
| − | |||
| Zeile 56: | Zeile 53: | ||
| − | |||
| − | |||
| Zeile 68: | Zeile 63: | ||
| − | + | ||
{{tp|p=32369614|t=2020. Concomitant haemorrhagic syndrome and recurrent extensive arterial thrombosis in a patient with COVID-19 and acute promyelocytic leukaemia |pdf=|usr=}} | {{tp|p=32369614|t=2020. Concomitant haemorrhagic syndrome and recurrent extensive arterial thrombosis in a patient with COVID-19 and acute promyelocytic leukaemia |pdf=|usr=}} | ||
{{ttp|p=32369610|t=2020. Severe COVID-19 infection and thrombotic microangiopathy: success does not come easily |pdf=|usr=}} | {{ttp|p=32369610|t=2020. Severe COVID-19 infection and thrombotic microangiopathy: success does not come easily |pdf=|usr=}} | ||
| − | |||
| Zeile 78: | Zeile 72: | ||
| − | + | ||
| + | |||
{{tp|p=32333579|t=2020. (clin-hemorheol-microcirc) COVID-19 |pdf=|usr=}} | {{tp|p=32333579|t=2020. (clin-hemorheol-microcirc) COVID-19 |pdf=|usr=}} | ||
{{ttp|p=32294809|t=2020. Microvascular COVID-19 lung vessels obstructive thromboinflammatory syndrome (MicroCLOTS): an atypical acute respiratory distress syndrome working hypothesis |pdf=|usr=}} | {{ttp|p=32294809|t=2020. Microvascular COVID-19 lung vessels obstructive thromboinflammatory syndrome (MicroCLOTS): an atypical acute respiratory distress syndrome working hypothesis |pdf=|usr=}} | ||
| Zeile 112: | Zeile 107: | ||
{{tp|p=32324101|t=2020. Diagnosis, Prevention, and Treatment of Thromboembolic Complications in COVID-19: Report of the National Institute for Public Health of the Netherlands |pdf=|usr=}} | {{tp|p=32324101|t=2020. Diagnosis, Prevention, and Treatment of Thromboembolic Complications in COVID-19: Report of the National Institute for Public Health of the Netherlands |pdf=|usr=}} | ||
| − | + | ||
{{tp|p=32374544|t=2020. Risque thrombotique veineux induit par le SARS-CoV-2 : prevalence, recommandations et perspectives |pdf=|usr=}} | {{tp|p=32374544|t=2020. Risque thrombotique veineux induit par le SARS-CoV-2 : prevalence, recommandations et perspectives |pdf=|usr=}} | ||
{{tp|p=32378030|t=ä. COVID-19-Related Stroke |pdf=|usr=}} | {{tp|p=32378030|t=ä. COVID-19-Related Stroke |pdf=|usr=}} | ||
| Zeile 128: | Zeile 123: | ||
| − | + | ||
{{tp|p=32414639|t=ä. Bleeding in COVID-19 severe pneumonia: The other side of abnormal coagulation pattern?|pdf=|usr=}} | {{tp|p=32414639|t=ä. Bleeding in COVID-19 severe pneumonia: The other side of abnormal coagulation pattern?|pdf=|usr=}} | ||
| Zeile 136: | Zeile 131: | ||
{{tp|p=32402423|t=2020. Ten key points that vascular doctors learned very quickly about COVID-19 |pdf=|usr=}} | {{tp|p=32402423|t=2020. Ten key points that vascular doctors learned very quickly about COVID-19 |pdf=|usr=}} | ||
| − | |||
| − | |||
Version vom 11. Juni 2020, 10:32 Uhr
coviki.org collects the really good Ideas and the scientific Record on Covid-19 Virus.
Since there are many organ manifestations of Hypercoagulation, subcategorization and tranccategorization was applied.
- Venous thrombosis
- Pulmonary embolism
- Cerebral embolism
- Myocardial infarction
- Arterial embolism
- Microembolism
- Hypercoagulation
- Antiphospholipid antibodies
- Disseminated intravascular coagulation
- Bleeding
- Labwork of Thrombembolism
- Prophylaxis of Thrombembolism
The unifying concept behind is Dysendoheliosis with the components Coagulation /Microthrombi, proliferative or cytopathic obstructive Endotheliosis and mediator production as well as failure of the mitigating systems and secondary vasculitis.
32281926 2020. COVID-19 and haemostasis: a position paper from Italian Society on Thrombosis and Haemostasis (SISET)
32250159 2020. Hemorrhagic Problem Among the Patients With COVID-19: Clinical Summary of 41 Thai Infected Patients
32347323 ä. Facing COVID-19 in the ICU: vascular dysfunction, thrombosis, and dysregulated inflammation
32212240 2020. Disseminated intravascular coagulation in patients with 2019?nCoV pneumonia
32338320 ä. Covid-19 treatment update: follow the scientific evidence
32360371 ä. Thromboembolic events in patients with SARS-CoV-2
C7146714 ä. Incidence of thrombotic complications in critically ill ICU patients with COVID-19
32369614 2020. Concomitant haemorrhagic syndrome and recurrent extensive arterial thrombosis in a patient with COVID-19 and acute promyelocytic leukaemia
| 32369610 2020. Severe COVID-19 infection and thrombotic microangiopathy: success does not come easily |
32333579 2020. (clin-hemorheol-microcirc) COVID-19
| 32294809 2020. Microvascular COVID-19 lung vessels obstructive thromboinflammatory syndrome (MicroCLOTS): an atypical acute respiratory distress syndrome working hypothesis |
32302456 2020. Potential of heparin and nafamostat combination therapy for COVID-19
32359410 ä. Hypoxaemia related to COVID-19: vascular and perfusion abnormalities on dual-energy CT
32367749 2020. Transient appearance of EDTA dependent pseudothrombocytopenia in a patient with 2019 novel coronavirus pneumonia
32324101 2020. Diagnosis, Prevention, and Treatment of Thromboembolic Complications in COVID-19: Report of the National Institute for Public Health of the Netherlands
32374544 2020. Risque thrombotique veineux induit par le SARS-CoV-2 : prevalence, recommandations et perspectives
32378030 ä. COVID-19-Related Stroke
32133825 2020. Characteristics, causes, diagnosis and treatment of coagulation dysfunction in patients with COVID-19
32133824 2020. COVID-19 complicated with DIC: 2 cases report and literatures review
32283877 2020. Prognostic value of myocardial injury in patients with COVID-19
32344469 2020. DIC in COVID-19: Implications for Prognosis and Treatment?
32414639 ä. Bleeding in COVID-19 severe pneumonia: The other side of abnormal coagulation pattern?
32402423 2020. Ten key points that vascular doctors learned very quickly about COVID-19
C7177114 2020. Hypoxia in COVID-19: Sign of Severity or Cause for Poor Outcomes
32376101 2020. Association Between Hypoxemia and Mortality in Patients With COVID-19
32407937 2020. The clinical implication of dynamic neutrophil to lymphocyte ratio and D-dimer in COVID-19: A retrospective study in Suzhou China
| 32403033 2020. Targeting raised von Willebrand factor levels and macrophage activation in severe COVID-19: Consider low volume plasma exchange and low dose steroid |
32381264 2020. Confirmation of the high cumulative incidence of thrombotic complications in critically ill ICU patients with COVID-19: An updated analysis
32388068 2020. Thrombotic complications in critically ill patients with COVID 19
32291094 2020. Incidence of thrombotic complications in critically ill ICU patients with COVID-19
